Microarray study of mechanism of trichostatin a inducing apoptosis of Molt-4 cells

Zhenya Hong1, Zhiqiang Han, Min Xiao

  • 1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. hongzhenya@eyou.com

Insights

Trichostatin A (TSA) induces apoptosis in leukemia cells by altering gene expression, but spares normal cells. This histone deacetylase inhibitor shows promise for cancer therapy by selectively targeting cancer cell growth and survival mechanisms.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Histone deacetylase (HDAC) overexpression is linked to various cancers.
  • HDAC inhibitors like trichostatin A (TSA) induce cancer cell apoptosis, but mechanisms are unclear.

Purpose of the Study:

  • To investigate the global gene expression profiles of human leukemia Molt-4 cells treated with TSA.
  • To elucidate the mechanism of TSA-induced apoptosis and growth inhibition in leukemia cells.

Main Methods:

  • Flow cytometry, MTT assay, and DNA laddering to assess apoptosis.
  • Microarray analysis, RT-PCR, and Western blotting to detect gene and protein expression changes.

Main Results:

  • TSA induced dose- and time-dependent apoptosis in Molt-4 cells, sparing normal peripheral blood mononuclear cells (PBMCs).
  • Microarray analysis revealed significant upregulation and deregulation of genes involved in cell growth, differentiation, and survival.
  • Key genes like STAT5A and MYC were significantly downregulated post-TSA treatment.

Conclusions:

  • TSA exhibits selective growth-inhibiting and apoptosis-inducing effects on leukemia cells.
  • The mechanism involves modulation of pro-proliferation and anti-apoptosis gene expression profiles.